{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:29:38Z","timestamp":1785439778245,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The recent pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has elevated several clinical and scientific questions. These include how host genetic factors influence the pathogenesis and disease susceptibility. Therefore, the aim of this study was to evaluate the impact of interferon lambda 3 and 4 (<jats:italic>IFNL3\/4<\/jats:italic>) gene polymorphisms and clinical parameters on the resistance and susceptibility to coronavirus disease 2019 (COVID-19) infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 750 SARS-CoV-2 positive patients (375 survivors and 375 nonsurvivors) were included in this study. All single-nucleotide polymorphisms (SNPs) on <jats:italic>IFNL3<\/jats:italic> (rs12979860, rs8099917, and rs12980275) and <jats:italic>IFNL4<\/jats:italic> rs368234815 were genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR\u2013RFLP) method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, a higher viral load (low PCR Ct value) was shown in nonsurvivor patients. In survivor patients, the frequency of the favorable genotypes of <jats:italic>IFNL3\/4<\/jats:italic> SNPs (rs12979860 CC, rs12980275 AA, rs8099917 TT, and rs368234815 TT\/TT) was significantly higher than in nonsurvivor patients. Multivariate logistic regression analysis has shown that a higher low-density lipoprotein (LDL), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and PCR Ct value, and lower 25-hydroxyvitamin D, and also <jats:italic>IFNL3<\/jats:italic> rs12979860 TT, <jats:italic>IFNL3<\/jats:italic> rs8099917 GG, <jats:italic>IFNL3<\/jats:italic> rs12980275 GG, and <jats:italic>IFNL4<\/jats:italic> rs368234815 \u2206G\/\u2206G genotypes were associated with the severity of COVID-19 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results of this study proved that the severity of COVID-19 infection was associated with clinical parameters and unfavorable genotypes of <jats:italic>IFNL3\/IFNL4<\/jats:italic> SNPs. Further studies in different parts of the world are needed to show the relationship between severity of COVID-19 infection and host genetic factors<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-021-01692-z","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T19:02:32Z","timestamp":1636916552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Pooneh","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil","family":"Tarharoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rahimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Mosayebi Amroabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enayat","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-8523","authenticated-orcid":false,"given":"Abolfazl","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,14]]},"reference":[{"issue":"4","key":"1692_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1620\/tjem.250.271","volume":"250","author":"S Baloch","year":"2020","unstructured":"Baloch S, Baloch MA, Zheng T, Pei X. The coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med. 2020;250(4):271\u20138.","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"1692_CR2","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/jcm9103315","volume":"9","author":"E Amodio","year":"2020","unstructured":"Amodio E, Pipitone RM, Grimaudo S, Immordino P, Maida CM, Prestileo T, et al. SARS-CoV-2 viral load, IFN\u03bb polymorphisms and the course of COVID-19: an observational study. J Clin Med. 2020;9(10):3315.","journal-title":"J Clin Med"},{"issue":"2","key":"1692_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/1040841X.2020.1739001","volume":"46","author":"A Biswas","year":"2020","unstructured":"Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S. Emergence of novel coronavirus and COVID-19: whether to stay or die out? Crit Rev Microbiol. 2020;46(2):182\u201393.","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"1692_CR4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2020.05.016","volume":"181","author":"J-L Casanova","year":"2020","unstructured":"Casanova J-L, Su HC, COVID Human Genetic Effort. Effort CHG A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. 2020;181(6):1194\u20139.","journal-title":"Cell"},{"issue":"10223","key":"1692_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u201323.","journal-title":"Lancet"},{"issue":"7","key":"1692_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI van der Made","year":"2020","unstructured":"van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324(7):663\u201373.","journal-title":"JAMA"},{"key":"1692_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.meegid.2017.07.023","volume":"54","author":"F Sakhaee","year":"2017","unstructured":"Sakhaee F, Ghazanfari M, Vaziri F, Jamnani FR, Davari M, Gharibzadeh S, et al. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection. Infect Genet Evol. 2017;54:330\u20137.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"1692_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00705-016-3095-1","volume":"162","author":"P Sedighimehr","year":"2017","unstructured":"Sedighimehr P, Irani S, Sakhaee F, Vaziri F, Aghasadeghi M, Sadat SM, et al. IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C. Arch Virol. 2017;162(1):181\u20139.","journal-title":"Arch Virol"},{"issue":"3","key":"1692_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/gene.2017.12","volume":"18","author":"M Asnavandi","year":"2017","unstructured":"Asnavandi M, Zargar M, Vaziri F, Jamnani FR, Gharibzadeh S, Fateh A, et al. EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C. Genes Immun. 2017;18(3):144\u201351.","journal-title":"Genes Immun"},{"key":"1692_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2019.00340","volume":"9","author":"B Rugwizangoga","year":"2019","unstructured":"Rugwizangoga B, Andersson ME, Kabayiza JC, Nilsson MS, \u00c1rmannsd\u00f3ttir B, Aurelius J, et al. IFNL4 genotypes predict clearance of RNA viruses in Rwandan children with upper respiratory tract infections. Front Cell Infect Microbiol. 2019;9:340.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"1692_CR11","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","volume":"80","author":"N Ank","year":"2006","unstructured":"Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-\u03bb), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. 2006;80(9):4501\u20139.","journal-title":"J Virol"},{"issue":"9","key":"1692_CR12","doi-asserted-by":"publisher","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","volume":"4","author":"M Mordstein","year":"2008","unstructured":"Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, et al. Interferon-\u03bb contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 2008;4(9):e1000151.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1692_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000495172","volume":"51","author":"JH Zhou","year":"2018","unstructured":"Zhou JH, Wang YN, Chang QY, Ma P, Hu Y, Cao X. Type III interferons in viral infection and antiviral immunity. Cell Physiol Biochem. 2018;51(1):173\u201385.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1692_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/00365513.2017.1299207","volume":"77","author":"SH Monavari","year":"2017","unstructured":"Monavari SH, Fateh R, Vaziri F, Rahimi Jamnani F, Anvari E, Sadeghi F, et al. A comparative study of various methods for detection of IL28B rs12979860 in chronic hepatitis C. Scand J Clin Lab Invest. 2017;77(4):247\u201352.","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"1692_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/labmed\/lmw060","volume":"48","author":"M Pouryasin","year":"2017","unstructured":"Pouryasin M, Sharafi H, Behnava B, Alavian SM, Keshvari M, Pouryasin A. A simple PCR-RFLP method for genotyping of IFNL4 rs368234815 polymorphism in patients with chronic hepatitis C. Lab Med. 2017;48(1):51\u20136.","journal-title":"Lab Med"},{"issue":"11","key":"1692_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1503\/cmaj.1040398","volume":"171","author":"CM Chu","year":"2004","unstructured":"Chu CM, Poon LL, Cheng VC, Chan KS, Hung IF, Wong MM, et al. Initial viral load and the outcomes of SARS. CMAJ. 2004;171(11):1349\u201352.","journal-title":"CMAJ"},{"issue":"1","key":"1692_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13054-020-02893-8","volume":"24","author":"X Yu","year":"2020","unstructured":"Yu X, Sun S, Shi Y, Wang H, Zhao R, Sheng J. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Crit Care. 2020;24(1):170.","journal-title":"Crit Care"},{"issue":"1","key":"1692_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","volume":"11","author":"C Gebhard","year":"2020","unstructured":"Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29.","journal-title":"Biol Sex Differ"},{"key":"1692_CR19","doi-asserted-by":"crossref","unstructured":"Ambrosino I, Barbagelata E, Ortona E, Ruggieri A, Massiah G, Giannico OV, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020;90(2).","DOI":"10.4081\/monaldi.2020.1389"},{"issue":"1","key":"1692_CR20","doi-asserted-by":"publisher","first-page":"20191","DOI":"10.1038\/s41598-020-77093-z","volume":"10","author":"A Jain","year":"2020","unstructured":"Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep. 2020;10(1):20191.","journal-title":"Sci Rep"},{"issue":"4","key":"1692_CR21","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.7861\/clinmed.2020-0301","volume":"20","author":"EK Weir","year":"2020","unstructured":"Weir EK, Thenappan T, Bhargava M, Chen Y. Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond). 2020;20(4):e107\u20138.","journal-title":"Clin Med (Lond)"},{"issue":"7","key":"1692_CR22","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/nu5072502","volume":"5","author":"B Prietl","year":"2013","unstructured":"Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502\u201321.","journal-title":"Nutrients"},{"key":"1692_CR23","doi-asserted-by":"publisher","first-page":"i6583","DOI":"10.1136\/bmj.i6583","volume":"356","author":"AR Martineau","year":"2017","unstructured":"Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.","journal-title":"BMJ"},{"issue":"5","key":"1692_CR24","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","volume":"16","author":"J Xu","year":"2017","unstructured":"Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep. 2017;16(5):7432\u20138.","journal-title":"Mol Med Rep"},{"issue":"7","key":"1692_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","volume":"58","author":"BM Henry","year":"2020","unstructured":"Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021\u20138.","journal-title":"Clin Chem Lab Med"},{"key":"1692_CR26","doi-asserted-by":"crossref","unstructured":"Wang H, Yuan Z, Pavel MA, Jablonski SM, Jablonski J, Hobson R, et al. The role of high cholesterol in age-related COVID19 lethality. bioRxiv [Preprint]. 2021 June 28:2020.05.09.086249.","DOI":"10.1101\/2020.05.09.086249"},{"issue":"5","key":"1692_CR27","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130(5):2620\u20139.","journal-title":"J Clin Investig"},{"key":"1692_CR28","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3389\/fimmu.2017.01707","volume":"8","author":"EA Hemann","year":"2017","unstructured":"Hemann EA, Gale M Jr, Savan R. Interferon lambda genetics and biology in regulation of viral control. Front Immunol. 2017;8:1707.","journal-title":"Front Immunol"},{"issue":"6515","key":"1692_CR29","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585.","journal-title":"Science"},{"issue":"6515","key":"1692_CR30","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570.","journal-title":"Science"},{"issue":"5","key":"1692_CR31","doi-asserted-by":"publisher","first-page":"e20200653","DOI":"10.1084\/jem.20200653","volume":"217","author":"L Prokunina-Olsson","year":"2020","unstructured":"Prokunina-Olsson L, Alphonse N, Dickenson RE, Durbin JE, Glenn JS, Hartmann R, et al. COVID-19 and emerging viral infections: the case for interferon lambda. J Exp Med. 2020;217(5):e20200653.","journal-title":"J Exp Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01692-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T19:04:07Z","timestamp":1636916647000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01692-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,14]]},"assertion":[{"value":"27 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of PII (IR.PII.REC.1400.042) and was carried out according to the 1975 Declaration of Helsinki and relevant local regulations. Also, written informed consent was directly obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}